Sanofi India Limited has scheduled a meeting of its Board of Directors for Tuesday, 4th August 2026. The primary agenda of the meeting is to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th June 2026.
The company also referenced its previous intimation dated 26th June 2026 regarding the closure of the trading window. The trading window for the publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 remains closed from Wednesday, 1st July 2026 to Thursday, 6th August 2026 (both days inclusive).
The disclosure was signed by Haresh Bachubhai Vala, Company Secretary and Compliance Officer (Membership No.: A18246) on 20th July 2026 at 12:05:23 IST.